Covered recipient · General Payments record
MARY F KNOX
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,479.78
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,000.34 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $275.12 | 12 |
| Novo Nordisk AS | $268.43 | 19 |
| Lilly USA, LLC | $182.44 | 10 |
| PFIZER INC. | $102.13 | 5 |
| Tris Pharma Inc | $49.35 | 2 |
| Sumitomo Pharma America, Inc. | $44.05 | 2 |
| Axsome Therapeutics, Inc. | $21.26 | 1 |
| Janssen Pharmaceuticals, Inc | $20.56 | 1 |
| Masimo Corporation | $20.42 | 1 |
| Acerta Pharma LLC | $16.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.69 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833834 | CMS |
| ABBVIE INC. | $18.65 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833836 | CMS |
| ABBVIE INC. | $32.32 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833838 | CMS |
| ABBVIE INC. | $23.78 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833840 | CMS |
| ABBVIE INC. | $27.53 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833842 | CMS |
| ABBVIE INC. | $12.14 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833844 | CMS |
| ABBVIE INC. | $19.36 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833846 | CMS |
| ABBVIE INC. | $18.46 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833848 | CMS |
| ABBVIE INC. | $20.72 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833850 | CMS |
| ABBVIE INC. | $29.62 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833852 | CMS |
| ABBVIE INC. | $25.02 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833854 | CMS |
| ABBVIE INC. | $30.83 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103833856 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.58 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104489262 | CMS |
| Axsome Therapeutics, Inc. | $21.26 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148302620 | CMS |
| Janssen Pharmaceuticals, Inc | $20.56 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078073120 | CMS |
| Lilly USA, LLC | $18.88 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135181628 | CMS |
| Lilly USA, LLC | $20.42 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135200755 | CMS |
| Lilly USA, LLC | $17.63 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135169882 | CMS |
| Lilly USA, LLC | $19.28 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135169886 | CMS |
| Lilly USA, LLC | $20.96 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135194436 | CMS |
| Lilly USA, LLC | $13.23 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135191121 | CMS |
| Lilly USA, LLC | $16.24 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135200757 | CMS |
| Lilly USA, LLC | $20.29 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135191123 | CMS |
| Lilly USA, LLC | $18.81 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135169884 | CMS |
| Lilly USA, LLC | $16.70 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135194438 | CMS |
| Masimo Corporation | $20.42 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152317471 | CMS |
| Novo Nordisk Inc | $18.91 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096685322 | CMS |
| Novo Nordisk Inc | $10.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593740 | CMS |
| Novo Nordisk Inc | $17.85 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097776744 | CMS |
| Novo Nordisk Inc | $18.00 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096574094 | CMS |
| Novo Nordisk Inc | $7.94 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096838746 | CMS |
| Novo Nordisk Inc | $9.22 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097394459 | CMS |
| Novo Nordisk Inc | $12.67 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096589191 | CMS |
| Novo Nordisk Inc | $20.29 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097276054 | CMS |
| Novo Nordisk Inc | $16.92 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097593059 | CMS |
| Novo Nordisk Inc | $7.01 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096917580 | CMS |
| Novo Nordisk Inc | $21.90 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097525087 | CMS |
| Novo Nordisk Inc | $7.14 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096699145 | CMS |
| Novo Nordisk Inc | $17.76 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097362463 | CMS |
| Novo Nordisk Inc | $15.53 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097283976 | CMS |
| Novo Nordisk Inc | $2.92 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097331987 | CMS |
| Novo Nordisk Inc | $23.92 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097069521 | CMS |
| Novo Nordisk Inc | $18.65 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097081989 | CMS |
| Novo Nordisk Inc | $6.10 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096905649 | CMS |
| Novo Nordisk Inc | $14.78 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892253 | CMS |
| PFIZER INC. | $20.25 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605493 | CMS |
| PFIZER INC. | $17.67 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605497 | CMS |
| PFIZER INC. | $20.44 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605505 | CMS |
| PFIZER INC. | $21.18 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605501 | CMS |
| PFIZER INC. | $22.59 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131605509 | CMS |
| Sumitomo Pharma America, Inc. | $22.10 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148858657 | CMS |
| Sumitomo Pharma America, Inc. | $21.95 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148858659 | CMS |
| Tris Pharma Inc | $24.81 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147236699 | CMS |
| Tris Pharma Inc | $24.54 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147236697 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.